FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline <i>BRCA</i>-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy

Geoffrey Kim, Richard Pazdur, Haw-Jyh Chiu et al.|Clinical Cancer Research|2015

Cited by 526